Comment on: Rescue therapy of anti-synthetase syndrome with CD19-targeted CART cells after failure of several B cell-depleting antibodies: reply.

Taubmann J, Knitza J, Müller F, Völkl S, Aigner M, Kretschmann S, Atzinger A, Kuwert T, Mackensen A, Schett G (2024)

Publication Type: Journal article

Publication year: 2024

Journal

Rheumatology Oxford University Press

Book Volume: 63

Pages Range: e312-e314

Journal Issue: 11

DOI: 10.1093/rheumatology/kead669

Authors with CRIS profile

Jule Taubmann Department of Medicine 3 – Rheumatology and Immunology Johannes Knitza Department of Medicine 3 – Rheumatology and Immunology Fabian Müller Professur für CAR-T-Zell-Therapie Simon Völkl Department of Medicine 5 – Haematology and Oncology Sascha Kretschmann Department of Medicine 5 – Haematology and Oncology Armin Atzinger Department of Nuclear Medicine Torsten Kuwert Lehrstuhl für Klinische Nuklearmedizin Andreas Mackensen Lehrstuhl für Innere Medizin V Georg Schett Lehrstuhl für Innere Medizin III

How to cite

APA:

Taubmann, J., Knitza, J., Müller, F., Völkl, S., Aigner, M., Kretschmann, S.,... Schett, G. (2024). Comment on: Rescue therapy of anti-synthetase syndrome with CD19-targeted CART cells after failure of several B cell-depleting antibodies: reply. Rheumatology, 63(11), e312-e314. https://doi.org/10.1093/rheumatology/kead669

MLA:

Taubmann, Jule, et al. "Comment on: Rescue therapy of anti-synthetase syndrome with CD19-targeted CART cells after failure of several B cell-depleting antibodies: reply." Rheumatology 63.11 (2024): e312-e314.

BibTeX: Download